نتایج جستجو برای: donepezil

تعداد نتایج: 1452  

Journal: :Drug metabolism and disposition: the biological fate of chemicals 1999
K Matsui M Mishima Y Nagai T Yuzuriha T Yoshimura

Donepezil hydrochloride (Aricept) is a drug for the treatment of Alzheimer's disease. The absorption, distribution, metabolism, and excretion of donepezil were investigated in male Sprague-Dawley rats after a single oral administration. Orally administered (14)C-labeled donepezil was absorbed rapidly. The plasma level of unchanged donepezil declined more rapidly than that of radioactivity, and ...

Journal: :Stroke 2010
Gustavo C Román Stephen Salloway Sandra E Black Donald R Royall Charles Decarli Michael W Weiner Margaret Moline Dinesh Kumar Rachel Schindler Holly Posner

BACKGROUND AND PURPOSE We sought to assess the efficacy and safety of donepezil in patients with vascular dementia (VaD) fulfilling National Institute of Neurological Disorders and Stroke-Association Internationale pour la Recherche et l'Enseignement en Neurosciences criteria. METHODS This international, multicenter, 24-week trial was conducted from March 2003 to August 2005. Patients (N=974;...

2011
Rodrigo Riveros Hughes Chabriat Rodrigo Flores Gonzalo Alvarez Andrea Slachevsky

OBJECTIVE To examine the effect of donepezil for the treatment of cognitive and behavioral disorders associated with thalamic lesions in a 45-year-old male who suffered an infarct in the left thalamus. BACKGROUND Recent studies suggest that donepezil may improve executive functions impairments due to subcortical ischemic lesions. METHOD The effects of donepezil were analyzed in a single-cas...

2009

characterized by a deficiency in central cholinergic neurotransmission. Donepezil hydrochloride, (¡3⁄4)-2-[(1-benzylpiperidin-4-yl)methyl]-5,6dimethoxyindan-1-one monohydrochloride, is a reversible acetylcholinesterase inhibitor that has been reported to have a high potency and selectivity for centrally active cholinesterase. Matsui and co-workers reported that the concentration and area under ...

Journal: :The New England journal of medicine 2007
Robert J Howard Edmund Juszczak Clive G Ballard Peter Bentham Richard G Brown Roger Bullock Alistair S Burns Clive Holmes Robin Jacoby Tony Johnson Martin Knapp James Lindesay John T O'Brien Gordon Wilcock Cornelius Katona Roy W Jones Julia DeCesare Michaela Rodger

BACKGROUND Agitation is a common and distressing symptom in patients with Alzheimer's disease. Cholinesterase inhibitors improve cognitive outcomes in such patients, but the benefits of these drugs for behavioral disturbances are unclear. METHODS We randomly assigned 272 patients with Alzheimer's disease who had clinically significant agitation and no response to a brief psychosocial treatmen...

Journal: :NeuroImage 2009
Kotaro Hiraoka Nobuyuki Okamura Yoshihito Funaki Shoichi Watanuki Manabu Tashiro Motohisa Kato Akiko Hayashi Yoshiyuki Hosokai Hiroshi Yamasaki Toshikatsu Fujii Etsuro Mori Kazuhiko Yanai Hiroshi Watabe

The aim of this study was to establish kinetic analysis of [5-(11)C-methoxy]donepezil ([(11)C]donepezil), which was developed for the in-vivo visualization of donepezil binding to acetylcholinesterase (AChE) using positron emission tomography (PET). Donepezil is an AChE inhibitor that is widely prescribed to ameliorate the cognitive impairment of patients with dementia. Six healthy subjects too...

2012
Susanne Hartz Denis Getsios Sunning Tao Steve Blume Grant Maclaine

BACKGROUND Previous cost-effectiveness studies of cholinesterase inhibitors have modeled Alzheimer's disease (AD) progression and treatment effects through single or global severity measures, or progression to "Full Time Care". This analysis evaluates the cost-effectiveness of donepezil versus memantine or no treatment in Germany by considering correlated changes in cognition, behavior and func...

2012
Ryohei Miyazaki Toshihiro Ichiki Toru Hashimoto Jiro Ikeda Aya Kamiharaguchi Eriko Narabayashi Hirohide Matsuura Kotaro Takeda Kenji Sunagawa

Donepezil {(RS)-2-[(1-benzyl-4-piperidyl)methyl]-5,6-dimethoxy-2,3-dihydroinden-1-one} is a reversible acetylcholinesterase inhibitor and used for treatment of patients with AD (Alzheimer's disease). Recent studies showed that treatment with donepezil reduced production of inflammatory cytokines in PBMCs (peripheral blood mononuclear cells). It was also reported that muscle-derived inflammatory...

2015
Henry C. Ndukwe Prasad S. Nishtala

BACKGROUND Donepezil is indicated for the management of mild to moderate dementia, particularly in Alzheimer's disease. Several studies have described low adherence rates with donepezil. AIM To examine and measure donepezil adherence, persistence and time to first discontinuation in older New Zealanders. METHODS An inception cohort of 1,999 new users of donepezil, aged 65 years or older, we...

Journal: :Neural regeneration research 2016
Qiang Liu Xiu-Juan Wang Zhe-Cheng Zhang Rong Xue Ping Li Bo Li

Acupuncture can be used to treat various nervous system diseases. Here, 168 vascular dementia patients were orally administered donepezil hydrochloride alone (5 mg/day, once a day for 56 days), or combined with acupuncture at Shenting (DU24), Tianzhu (BL10), Sishencong (Extra), Yintang (Extra), Renzhong (DU26), Neiguan (PC6), Shenmen (HT7), Fengchi (GB20), Wangu (GB12) and Baihui (DU20) (once a...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید